Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000301
Chunk: 93

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 93
---
 The terms of such contract shall provide for payment in full of the purchase price upon completion  
 and may require the holders of the C Deferred Shares concerned to sell such shares for a price not exceeding 1 penny for all the C Deferred 
 Shares so purchased. If such a resolution is passed and the Company is in all other respects able and willing to purchase the C Deferred    
 Shares to which the contract relates in accordance with Sections 690 to 708 of the Act, the Company shall have irrevocable authority to     
 appoint any person: (i) to execute such contract on behalf of each of the holders of the relevant C Deferred Shares; (ii) to execute a      
 stock transfer form (or forms) sufficient in every respect to transfer to the Company the legal title to the C Deferred Shares that are     
 the subject of such contract, and (iii) to receive at completion the purchase price on behalf of the holders of the C Deferred Shares.      
 From the time that such resolution is passed, the holders of the C Deferred Shares that are the subject of such contract shall hold such    
 shares as bare trustee for the Company.                                                                                                     |

| 145.3 | -A | Subject to the Act, the Company may, at its option, cancel C Deferred Shares by way of a reduction 
 of capital for no consideration; and/or                                                            |

| (B) | Pending any such transfer and/or purchase and/or cancellation, the Company may retain any share certificate 
 that may be issued in respect of any of the C Deferred Shares.                                              |

| 146 | FORUM SELECTION |

| 146.1 | Unless the Company consents in writing to the selection of an alternative forum, the courts of England 
 and Wales shall, to the fullest extent permitted by law, be the sole and exclusive forum for:          |

| (A) | any derivative action or proceeding brought on behalf of the Company; |

| (B) | any action including any action commenced by a member of the Company in its own name or on behalf of the                                      
 Company, asserting a claim of breach of any fiduciary or other duty owed by any director, officer or other employee of the Company (including 
 but not limited to duties arising under the Act); or                                                                                          |

| 71 |

| (C) | an action arising out of or in connection with these Articles (pursuant to any provision of the laws of                         
 England and Wales or the Company’s memorandum of association and Articles (as either may be may be amended from